Regis Technologies, Inc.

Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help expedite their drug candidates to market. Regis offers a comprehensive range of services to support the development of lead molecules from preclinical and clinical API needs through commercialization, including process research and development, solid state chemistry, analytical development and stability services, and GMP API manufacturing. In addition to our extensive API development and manufacturing services, we also offer an innovative line of proprietary chromatography products sold throughout the world. Regis is privately owned and operated and has been in business in the Chicago area since 1956.